| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.68B | +45.5% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥0.17B | — |
| Net income | ¥0.13B | +320.4% |
| Gross margin | 9.1% | Net margin 19.1% |
| Revenue Q/Q | +18.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.61B | 90.9% |
| R&D | ¥0.02B | 2.7% |
| SG&A | ¥0.03B | 5.0% |
| Tax & other | ¥0.04B | 6.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
普瑞眼科 ・ 宏源药业 ・ 杰创智能 ・ 威尔高 ・ 同星科技 ・ 通力科技 ・ 华融化学 ・ 普蕊斯 ・ 富士莱 ・ 艾布鲁 ・ 格力博 ・ 恒工精密
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies